CTBP2P8

Across TCGA pan-cancer cohorts, CTBP2P8 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated CTBP2P8 data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher CTBP2P8 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated CTBP2P8 expression acts as an unfavorable survival marker, although some lineages such as BRCA and OV show a favorable association.

BRCA, LGG, and OV are the cancer types where CTBP2P8 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	DFS	Quartile	III,IV	0.689	0.441	.001	66	view →
LGG	DFS	Median	All	0.277	0.498	<.001	54	view →
OV	DFS	Median	IV	0.571	0.364	.010	42	view →
ACC	OS	Median	All	0.766	0.977	.001	31	view →
UCS	DFS	Median	IV	0.952	0.367	.001	26	view →
BLCA	OS	Median	All	0.475	0.667	.017	23	view →
COAD	DFS	Quartile	IV	0.349	0.695	.014	15	view →
LUSC	DFS	Median	III,IV	0.461	0.916	.001	14	view →
MESO	DFS	Quartile	All	0.286	0.510	.004	12	view →
SKCM	OS	Median	III,IV	0.276	0.631	.004	9	view →
KIRC	DFS	Tertile	All	0.908	0.790	.027	8	view →
KICH	DFS	Median	III,IV	0.509	0.900	.038	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

CTBP2P8–BRCA (DFS)

Open the BRCA breakdown →